Skip to content

imarranz/imarranz

Folders and files

NameName
Last commit message
Last commit date

Latest commit

ย 
ย 
ย 
ย 
ย 
ย 
ย 

Repository files navigation

๐Ÿ‘จโ€๐Ÿ’ป About Me

Hi ๐Ÿ‘‹, I'm Ibon

I am Ibon Martรญnez-Arranz and I got my BSc. in Mathematics from the University of the Basque Country (EHU/UPV) and performed a MSc. in Current Applied Statistics Techniques and a MSc. in Mathematical Modeling Research, Statistical Analysis and Computing Sciences. In 2004, I joined the Basque Country Health Service (The Department of Health of the Basque Country Government and Osakidetza) as a data analyst and my work was mainly focused on the epidemiological report of renal patients. When I joined OWL Metabolomics in 2010, first I worked as a researcher in the Metabolomics Department and in 2017, I became the head of the Data Science Department, being responsible for prediction and statistical computation management since then. This high experience provide support to metabolomics services, laboratory processes, data handling, R&D projects and technology transfer processes.

Education
INSTITUTION
AND LOCATION
DEGREE COMPLETION
DATE
FIELD OF
STUDY
University of Basque Country (UPV/EHU) (Biscay, Spain) BSc. 06/2003 Mathematics
National University of Distance Education (Spain) Expert degree 07/2007 Statistics Applied to Health Sciences
National University of Distance Education (Spain) Expert degree 07/2008 Advanced Methods of Applied Statistics
National University of Distance Education (Spain) MSc. 07/2012 Current Applied Statistics Techniques
National University of Distance Education (Spain) Expert degree 07/2013 Multivariate Statistical Techniques
University of Basque Country (UPV/EHU) (Biscay, Spain) MSc. 05/2016 Mathematical Modeling, Statistical Analysis and Computation
University of basque Country (UPV/EHU) (Biscay, Spain) Ongoing PhD. Expected 2024 Applied Mathematics

Currently, I am doing a doctoral thesis entitled Genetic Algorithms Applied to Translational Strategy in NASH. Learning from Mouse Models in which I apply ๐Ÿงฌ genetic algorithms ๐Ÿงฌ for the selection of NAFLD subtypes. This procedure could be applied to any disease that is based on metabolic changes. This work also has implications in the field of precision medicine.

Contributions to Science
Author of 24 publications. Scopus H-index = 16. Researcher unique identifier

Data Science of 'omics' data

'Omics' research generates a large amount of data for every sample. OWL has established a well-defined workflow and a set of guidelines for analyzing omics data. It includes statistical design of experiments, data structuration and predictive modelling.

Peer-reviewed papers:

  1. Martรญnez-Arranz, I, et al. Enhancing metabolomics research through data mining, J. Proteomics, 2015;127(B)275-288.
  2. Barr J, et al. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J. Proteome Res 2012;11(4),2521-32
  3. Arbelaiz A, et al. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2017; 10.1002/hep.29291.
  4. Cano A, et al. A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients. Scientific Reports. 2017;7(1):10497.

Predictive algorithms for disease diagnosis

We have developed predictive algorithms for several diseases. We have been really involved in the development and validation of the OWLiver, OWLiver F2+ and OWLiver DM2 tests.

Peer-reviewed papers:

  1. Barr J, et al. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J. Proteome Res. 2012;11(4):2521-32.
  2. Cano A, et al. A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients. Scientific Reports. 2017;7(1):10497.
  3. Herreros-Villanueva M, et al. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. Clin Transl Gastroenterol. 2019 Jan;10(1).
  4. Matorras R, et al. The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles. J Assist Reprod Genet. 2020;37(2):385-94.
  5. Martรญnez-Arranz I, et al. Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts. Hepatol Commun. 2018 May 4;2(7):807-820.

Selected publications focused in Machine Learning and Modelling (within last 5 years)

Peer-reviewed papers:

  1. Alonso C, et al. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. Gastroenterology 2017;152(6):1449-61.
  2. Iruarrizaga-Lejarreta M, et al. Role of Aramchol in steatohepatitis and fibrosis in mice. Hepatology Communications 2017;1(9):911-27.
  3. Banales JM, et al. Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis. Hepatology 2019;70(2):547-65.
  4. Herreros-Villanueva M, et al. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. Clin Transl Gastroenterol. 2019 Jan;10(1).
  5. Matorras R, et al. The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles. J Assist Reprod Genet. 2020;37(2):385-94.
Skills
TOPIC SOFTWARE SKILLS
Programming Languages for Data Science Python
R
SQL
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœ
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœ
Data Analysis Pandas
Pingouin
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ
Data Computation Numpy
Scipy
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœ
Data Bases MySQL
SQLite
MongoDB
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœโฌœ
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœ
๐ŸŸฅ๐ŸŸฅโฌœโฌœโฌœ
Machine Learning Scikit-Learn ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœ
Big Data H2O ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœ
Visualization Tools Matplotlib
Seaborn
Altair
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœ
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœ
Web Shiny
Streamlit
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœ
๐ŸŸฅ๐ŸŸฅ๐ŸŸฅโฌœโฌœ
Patents and Pendings
PUBLICATION
NUMBER
TITLE INTERNATIONAL
FILING DATE
WO2021028562 Lipid signatures for determining the outcome of embryo implantation during in vitro fertilization 14.08.2020
WO2018007511 Diagnostic methods based on lipid profiles 06.07.2017
WO2018007422 Identification of human Non-Alcoholic Fatty Liver Disease (NAFLD) subtypes 05.07.2017
WO2017055397 Metabolomic signature of diagnosis and disease progression in Non-Alcoholic Fatty Liver Disease (NAFLD) 29.09.2016

๐Ÿ”ฌ Scientific Production

Pubmed ORCID Scopus Kaggle

Publications

๐ŸŸจ NAFLD Disease ๐ŸŸฉ Subtypes ๐ŸŸง Machine Learning and Modelling ๐ŸŸช In Vitro Diagnostic test

ARTICLE DOI PURPOSE
Serum identification of At-Risk MASH: The Metabolomics-Advanced steatohepatitis fibrosis score (MASEF) ๐ŸŸจ๐ŸŸง๐ŸŸช
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy. (2023) ๐ŸŸง
Metabolic subtypes of nonalcoholic fatty liver disease patients exhibit distinctive cardiovascular risk profiles. (2022) ๐ŸŸจ๐ŸŸฉ๐ŸŸง
A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. (2020) ๐ŸŸง
Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122. (2020) ๐ŸŸจ
CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort. (2020) ๐ŸŸง
The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles. (2020) ๐ŸŸง
Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis. (2019) ๐ŸŸจ๐ŸŸง๐ŸŸช
Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. (2019) ๐ŸŸง
Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis. (2019) ๐ŸŸง
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis. (2019) ๐ŸŸง
Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr-/-.Leiden Mice. (2018) ๐ŸŸฉ
Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer. (2018) ๐ŸŸง
Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts. (2018) ๐ŸŸจ๐ŸŸง๐ŸŸช
Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. (2018) ๐ŸŸจ๐ŸŸง๐ŸŸช
Role of Aramchol in steatohepatitis and fibrosis in mice. (2017) ๐ŸŸจ๐ŸŸฉ๐ŸŸง
A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients. (2017) ๐ŸŸง
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. (2017) ๐ŸŸจ๐ŸŸฉ๐ŸŸง
Data in support of enhancing metabolomics research through data mining. (2015) ๐ŸŸง
Enhancing metabolomics research through data mining. (2015) ๐ŸŸง
Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. (2013) ๐ŸŸง
Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease. (2013) ๐ŸŸง
Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression. (2012) ๐ŸŸจ๐ŸŸง

๐Ÿ” More Details

  • ๐Ÿ“Œ Iโ€™m currently working as ๐Ÿ“Š Senior Data Scientist ๐Ÿ“Š @ OWL Metabolomics.
  • ๐Ÿ“Œ Iโ€™m currently learning Streamlit, Panel and MongoDB, ...
  • ๐Ÿ“Œ I'm interested in: ๐Ÿ‘จโ€๐Ÿ”ฌ Data Science ๐Ÿ Python ๐Ÿผ Pandas ๐Ÿค– Machine Learning ๐Ÿ—‚๏ธ SQL and DataBases ๐Ÿ“Š Data Analysis ๐Ÿš€ SKlearn
  • ๐Ÿ“Œ I want to learn about: โš™๏ธ awk
  • ๐Ÿ“Œ I use daily: .ipynb, .py, .sql, .sqlite, .yaml, .R, .tex, ...
  • ๐Ÿ“Œ Ask me about ๐Ÿงฌ Genetic Algorithms ๐Ÿงฌ
  • ๐Ÿ“Œ I Love Data Visualization ๐Ÿ“Š๐Ÿ“ˆ๐Ÿ“‰.
  • ๐Ÿ“Œ Fun fact: I'm a huge fan of The Lord of the Rings and LEGOยฎ

๐Ÿš€ Personal Projects


๐Ÿ”ฅ GitHub Stats


๐Ÿ“ซ How to Reach Me

Github Twiter Gmail LinkedIn

About

No description, website, or topics provided.

Resources

Stars

Watchers

Forks

Releases

No releases published

Packages

No packages published